Product Information

TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $15.8422 per EA under NDC 43598094230. Its NADAC has been published 39 times since Feb 25, 2026.

FDA first approved this application on Nov 17, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 200 MG CAPSULE

Topiramate
$15.8422per EA

Strength

200 mg/1

NDC

43598094230

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217231

FDA Approved

11/17/2023

TE Code

AB1

On Market Since

2/1/2026

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 39 times since Feb 25, 2026, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.

Current price$15.8422 per EA
All-time high$23.7461 (Aug 12, 2026)
All-time low$15.8422 (Nov 18, 2026)
52-week high$23.7461
52-week low$15.8422
Median price$22.7052
Average price$21.9000
Largest weekly change-14.5% (Oct 21, 2026)
Weeks tracked39
Tracking sinceFeb 25, 2026

Price History

1W

-9.0%

1M

-22.2%

3M

-31.5%

6M

-30.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-31.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $15.8422 per EA (NDC 43598094230), effective Nov 18, 2026.

How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has declined 31.6%. It has been tracked across 39 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?

Since Feb 25, 2026, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $15.8422 (Nov 18, 2026) to a high of $23.7461 (Aug 12, 2026), with a median of $22.7052 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 200 MG SPRINK CAP, is $11.1704 per EA — about 29% below TOPIRAMATE ER 200 MG CAPSULE.

Who manufactures TOPIRAMATE ER 200 MG CAPSULE?

TOPIRAMATE ER 200 MG CAPSULE (NDC 43598094230) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.